Pill is said to protect 75 percent of HIV infection
The American Food and Drug Administration (FDA) is currently reviewing the approval of the first anti-HIV pill, the use of which is said to significantly reduce the risk of infection. So far, only condoms have protected against infection with the HIV virus.
New pill is said to reduce the risk of HIV infection by up to 75 percent
AIDS is still one of the curable diseases. In contrast to many other virus-borne diseases, AIDS does not only occur in certain regions but as a pandemic. While great advances in drug therapy have been made thanks to intensive research that may delay the onset of AIDS after HIV infection, a full recovery still seems a long way off.
Now a committee of US experts has issued a recommendation to the FDA for approval of the first anti-HIV pill. The "Truvada" pill, which is produced by the pharmaceutical company Gilead Sciences, is intended to preventively prevent infection with HIV. After the 22 independent experts completed an 11-hour session and further hearings, the majority voted on Thursday for the commercial launch of the anti-HIV pill. While the Commission's recommendation is not binding on the FDA, it generally follows it.
A clinical study showed that "Truvada" reduces the risk of infection in heterosexuals with a seropositive partner by up to 75 percent. The drug is already used with other drugs for the therapy of HIV infections. (ag)
How to deal with HIV infections correctly
Tablets are said to reduce HIV infection risk?
30 years of AIDS: still no cure in sight?
Two million young people infected with HIV worldwide
China: Clinics deny AIDS patients
UN warns of rapid spread of AIDS
AIDS: SI virus is considered a precursor to HIV
Why some do not get AIDS despite HIV
AIDS: no fate with correct antibodies?
Image: Gerd Altmann, Pixelio.de